tiprankstipranks
Trending News
More News >
Abbott Laboratories (CH:ABT)
:ABT
Switzerland Market

Abbott Laboratories (ABT) Ratios

Compare
1 Followers

Abbott Laboratories Ratios

CH:ABT's free cash flow for Q1 2025 was $0.57. For the 2025 fiscal year, CH:ABT's free cash flow was decreased by $ and operating cash flow was $0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.63 1.64 1.63 1.85 1.72
Quick Ratio
1.23 1.16 1.23 1.46 1.30
Cash Ratio
0.64 0.50 0.64 0.75 0.57
Solvency Ratio
0.27 0.26 0.27 0.27 0.20
Operating Cash Flow Ratio
0.62 0.52 0.62 0.80 0.66
Short-Term Operating Cash Flow Coverage
4.26 6.72 4.26 13.97 35.91
Net Current Asset Value
$ -12.31B$ -11.72B$ -12.31B$ -14.93B$ -19.10B
Leverage Ratios
Debt-to-Assets Ratio
0.24 0.22 0.24 0.25 0.27
Debt-to-Equity Ratio
0.48 0.41 0.48 0.53 0.60
Debt-to-Capital Ratio
0.33 0.29 0.33 0.35 0.37
Long-Term Debt-to-Capital Ratio
0.28 0.26 0.28 0.33 0.36
Financial Leverage Ratio
2.03 1.90 2.03 2.10 2.21
Debt Service Coverage Ratio
4.19 5.63 4.19 9.33 11.52
Interest Coverage Ratio
22.30 10.17 22.30 17.19 10.71
Debt to Market Cap
0.09 0.08 0.09 0.07 0.10
Interest Debt Per Share
10.32 9.52 10.32 10.98 11.36
Net Debt to EBITDA
0.63 0.85 0.63 0.72 1.46
Profitability Margins
Gross Profit Margin
56.15%55.18%56.15%56.97%56.65%
EBIT Margin
20.31%18.20%20.31%20.30%15.93%
EBITDA Margin
28.36%26.44%28.36%29.58%25.40%
Operating Profit Margin
19.16%16.15%19.16%19.56%15.48%
Pretax Profit Margin
19.03%16.61%19.03%19.06%14.36%
Net Profit Margin
15.88%14.27%15.88%16.42%12.99%
Continuous Operations Profit Margin
15.88%14.27%15.88%16.42%12.92%
Net Income Per EBT
83.47%85.88%83.47%86.12%90.48%
EBT Per EBIT
99.33%102.87%99.33%97.46%92.74%
Return on Assets (ROA)
9.31%7.82%9.31%9.40%6.20%
Return on Equity (ROE)
18.90%14.83%18.90%19.75%13.71%
Return on Capital Employed (ROCE)
14.19%10.91%14.19%13.57%8.83%
Return on Invested Capital (ROIC)
11.36%9.17%11.36%11.50%7.89%
Return on Tangible Assets
16.83%14.05%16.83%18.03%13.21%
Earnings Yield
3.60%3.00%3.60%2.83%2.32%
Efficiency Ratios
Receivables Turnover
7.02 6.11 7.02 6.64 5.40
Payables Turnover
4.15 4.19 4.15 4.21 3.80
Inventory Turnover
3.10 2.74 3.10 3.59 2.99
Fixed Asset Turnover
4.76 3.56 4.76 4.81 3.83
Asset Turnover
0.59 0.55 0.59 0.57 0.48
Working Capital Turnover Ratio
4.18 4.32 4.18 4.38 5.19
Cash Conversion Cycle
81.85 105.94 81.85 69.72 93.58
Days of Sales Outstanding
51.99 59.74 51.99 54.97 67.65
Days of Inventory Outstanding
117.71 133.41 117.71 101.54 121.93
Days of Payables Outstanding
87.85 87.21 87.85 86.80 96.00
Operating Cycle
169.70 193.15 169.70 156.51 189.58
Cash Flow Ratios
Operating Cash Flow Per Share
5.47 4.19 5.47 5.93 4.46
Free Cash Flow Per Share
4.45 2.92 4.45 4.87 3.23
CapEx Per Share
1.01 1.27 1.01 1.06 1.23
Free Cash Flow to Operating Cash Flow
0.81 0.70 0.81 0.82 0.72
Dividend Paid and CapEx Coverage Ratio
1.88 1.26 1.88 2.07 1.67
Capital Expenditure Coverage Ratio
5.39 3.30 5.39 5.59 3.63
Operating Cash Flow Coverage Ratio
0.54 0.46 0.54 0.55 0.40
Operating Cash Flow to Sales Ratio
0.22 0.18 0.22 0.24 0.23
Free Cash Flow Yield
4.05%2.65%4.05%3.46%2.95%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
27.76 33.35 27.76 35.33 43.19
Price-to-Sales (P/S) Ratio
4.41 4.76 4.41 5.80 5.61
Price-to-Book (P/B) Ratio
5.25 4.94 5.25 6.98 5.92
Price-to-Free Cash Flow (P/FCF) Ratio
24.66 37.73 24.66 28.89 33.91
Price-to-Operating Cash Flow Ratio
20.09 26.29 20.09 23.72 24.57
Price-to-Earnings Growth (PEG) Ratio
-36.74 -2.05 -36.74 0.61 1.99
Price-to-Fair Value
5.25 4.94 5.25 6.98 5.92
Enterprise Value Multiple
16.18 18.84 16.18 20.33 23.54
Enterprise Value
200.30B 199.85B 200.30B 259.02B 206.94B
EV to EBITDA
16.18 18.84 16.18 20.33 23.54
EV to Sales
4.59 4.98 4.59 6.01 5.98
EV to Free Cash Flow
25.67 39.50 25.67 29.95 36.15
EV to Operating Cash Flow
20.91 27.52 20.91 24.59 26.19
Tangible Book Value Per Share
2.08 3.65 2.08 0.03 -3.12
Shareholders’ Equity Per Share
20.93 22.26 20.93 20.17 18.49
Tax and Other Ratios
Effective Tax Rate
0.17 0.14 0.17 0.14 0.10
Revenue Per Share
24.90 23.13 24.90 24.27 19.52
Net Income Per Share
3.95 3.30 3.95 3.98 2.54
Tax Burden
0.83 0.86 0.83 0.86 0.90
Interest Burden
0.94 0.91 0.94 0.94 0.90
Research & Development to Revenue
0.07 0.07 0.07 0.06 0.07
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.01 0.02
Income Quality
1.38 1.27 1.38 1.49 1.76
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis